StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
54
This year
4
Publishing Date
2024 - 02 - 22
1
2024 - 02 - 19
1
2024 - 01 - 30
1
2024 - 01 - 04
1
2023 - 12 - 05
1
2023 - 10 - 18
1
2023 - 06 - 27
2
2023 - 06 - 08
2
2023 - 05 - 15
1
2023 - 05 - 05
1
2023 - 04 - 26
2
2023 - 04 - 20
1
2023 - 04 - 13
1
2023 - 04 - 12
1
2023 - 03 - 27
1
2023 - 03 - 24
1
2023 - 03 - 01
1
2023 - 02 - 20
1
2023 - 02 - 10
1
2022 - 12 - 08
1
2022 - 12 - 02
1
2022 - 11 - 28
1
2022 - 11 - 04
1
2022 - 10 - 27
1
2022 - 10 - 19
1
2022 - 09 - 24
1
2022 - 09 - 19
1
2022 - 08 - 29
1
2022 - 08 - 03
1
2022 - 08 - 02
1
2022 - 07 - 01
1
2022 - 06 - 27
2
2022 - 06 - 08
1
2022 - 06 - 03
1
2022 - 05 - 30
1
2022 - 05 - 05
1
2022 - 04 - 06
1
2022 - 04 - 05
1
2022 - 04 - 02
1
2022 - 03 - 23
1
2022 - 02 - 01
1
2022 - 01 - 20
1
2021 - 11 - 24
1
2021 - 09 - 07
1
2021 - 08 - 23
1
2021 - 08 - 13
1
2021 - 08 - 05
2
2021 - 04 - 22
1
2021 - 03 - 16
1
Sector
Electronic technology
1
Health technology
54
Manufacturing
2
N/a
1
Technology services
4
Tags
Abbvie
7
Active
10
Agreement
10
America
46
Antibiotics
7
Antibody
9
Application
9
Approval
10
Biotech
26
Cancer
54
Care
11
Collaboration
11
Covid
34
Covid-19
25
Device
11
Diabetes
7
Disease
39
Distribution
11
Drug
110
Drug delivery
12
Earnings
7
Ema
7
Europe
17
Expected
28
Fda
14
Food
22
Genetown
9
Global
159
Growing
34
Growth
192
Health
22
Hiv
12
Infection
10
Infections
9
Influenza
9
Iot
19
License
10
Liver
15
Market
447
Merge
11
N/a
793
Nutrition
12
People
16
Pharma
11
Pharmaceuticals
12
Positive
12
Reach
24
Report
140
Research
88
Respiratory
16
Results
19
Risk
8
Set
14
System
11
Technology
23
Therapeutics
84
Therapy
24
Treatment
98
Trial
13
Vaccine
56
Entities
Abbott laboratories
49
Abbvie inc.
53
Accuray incorporated
26
Agenus inc.
21
Agilent technologies, inc.
27
Amgen inc.
91
Anixa biosciences, inc.
49
Astellas pharma inc
50
Astrazeneca plc
144
Aveo pharmaceuticals, inc.
24
Becton, dickinson and company
26
Beigene, ltd.
59
Biocept, inc.
31
Biontech se
21
Blueprint medicines corporation
27
Briacell therapeutics corp.
50
Bristol-myers squibb company
107
Castle biosciences, inc.
28
Clovis oncology, inc.
33
Eli lilly and company
139
Exact sciences corporation
56
Exelixis, inc.
43
G1 therapeutics, inc.
27
Genprex, inc.
26
Gilead sciences, inc.
59
Glaxosmithkline plc
54
Guardant health, inc.
54
Hologic, inc.
32
Hoth therapeutics, inc.
29
Illumina, inc.
68
Immunitybio inc
30
Immunogen, inc.
25
Immutep limited
34
Incyte corporation
57
Invitae corporation
25
Jaguar health, inc.
37
Johnson & johnson
139
Karyopharm therapeutics inc.
27
Lantern pharma inc.
25
Lixte biotechnology holdings inc.
22
Merck & company, inc.
75
Merus n.v.
24
Mirati therapeutics, inc.
32
Myriad genetics, inc.
50
Nanostring technologies, inc.
22
Natera, inc.
38
Novartis ag
106
Novocure limited
30
Oncolytics biotech inc.
41
Orange
138
Pds biotechnology corporation
35
Pfizer, inc.
66
Qiagen n.v.
31
Regeneron pharmaceuticals, inc.
42
Sanofi
217
Seagen inc.
55
Takeda pharmaceutical company limited
35
Thermo fisher scientific inc
51
Veracyte, inc.
46
Verastem, inc.
25
Symbols
A
1
ABBV
9
ABT
2
ADAP
3
ADBE
1
ADXS
1
ALPMF
2
ALPMY
2
AMGN
24
ANAB
2
AZN
28
AZNCF
23
BAX
6
BDX
1
BHC
2
BIIB
3
BMY
10
BNTX
1
CADL
1
CRNX
2
CTS
1
CVAC
1
CVM
1
DHR
1
DVAX
1
ENDP
1
EXEL
1
GILD
2
GLAXF
46
GMAB
2
GNLX
2
GNMSF
2
GOOG
1
GOOGL
1
GSK
54
HOLX
1
ICAD
3
ILMN
1
INCY
1
ITOS
1
JAZZ
2
JNJ
6
KURA
1
LLY
13
MGNX
1
MRNA
1
NBIX
1
NVO
1
NVS
34
NVSEF
32
ONCY
1
PBYI
3
PFE
8
PGEN
1
SNY
22
SNYNF
20
TAK
6
TEVJF
8
VTRS
5
ZNTL
2
Exchanges
Amex
1
Nasdaq
53
Nyse
54
Crawled Date
2024 - 02 - 22
1
2024 - 02 - 19
1
2024 - 01 - 30
1
2024 - 01 - 04
1
2023 - 12 - 05
1
2023 - 10 - 18
1
2023 - 06 - 27
2
2023 - 06 - 08
2
2023 - 05 - 15
1
2023 - 05 - 05
1
2023 - 04 - 26
2
2023 - 04 - 20
1
2023 - 04 - 13
1
2023 - 04 - 12
1
2023 - 03 - 27
1
2023 - 03 - 24
1
2023 - 03 - 01
1
2023 - 02 - 20
1
2023 - 02 - 10
1
2022 - 12 - 08
1
2022 - 12 - 02
1
2022 - 11 - 28
1
2022 - 11 - 04
1
2022 - 10 - 27
1
2022 - 10 - 19
1
2022 - 09 - 24
1
2022 - 09 - 19
1
2022 - 08 - 29
1
2022 - 08 - 03
1
2022 - 08 - 02
1
2022 - 07 - 01
1
2022 - 06 - 27
2
2022 - 06 - 08
1
2022 - 06 - 03
1
2022 - 05 - 30
1
2022 - 05 - 05
1
2022 - 04 - 06
1
2022 - 04 - 05
1
2022 - 04 - 02
1
2022 - 03 - 23
1
2022 - 02 - 01
1
2022 - 01 - 20
1
2021 - 11 - 24
1
2021 - 09 - 07
1
2021 - 08 - 23
1
2021 - 08 - 13
1
2021 - 08 - 05
2
2021 - 04 - 22
1
2021 - 03 - 16
1
Crawled Time
01:00
2
02:00
2
04:20
2
05:00
2
06:00
1
07:00
2
08:00
2
09:00
2
10:00
1
11:00
4
12:00
3
12:30
1
13:20
1
14:00
1
14:20
1
15:00
2
15:15
1
15:20
2
16:00
6
17:00
2
18:00
2
19:00
3
21:00
2
22:00
2
23:00
5
Source
www.biospace.com
4
www.curevac.com
1
www.globenewswire.com
1
www.prnewswire.com
48
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Cancer
entities :
Glaxosmithkline plc
save search
Non-Small Cell Lung Cancer (NSCLC) Market to Reach $29.95 Billion by 2028, Fueled by Advances in Therapy and Diagnostics
Published:
2024-02-22
(Crawled : 01:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
-8.95%
|
O:
0.14%
H:
0.0%
C:
-0.0%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-1.52%
|
O:
0.26%
H:
1.36%
C:
1.36%
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
10.47%
|
O:
-0.85%
H:
1.12%
C:
0.43%
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
-5.82%
|
O:
0.92%
H:
0.0%
C:
0.0%
UCBJY
|
$64.93
-4.38%
6.2K
|
Manufacturing
|
28.21%
|
O:
1.46%
H:
0.44%
C:
0.44%
ALPMY
|
News
|
$9.53
-1.11%
690K
|
Manufacturing
|
-14.66%
|
O:
-0.27%
H:
0.0%
C:
-1.17%
TAK
|
News
|
$13.38
0.15%
0.9%
1.7M
|
Health Technology
|
-9.46%
|
O:
-0.2%
H:
0.14%
C:
-0.48%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-3.61%
|
O:
-0.06%
H:
0.46%
C:
0.29%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
-1.67%
|
O:
-0.69%
H:
1.42%
C:
1.22%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-0.92%
|
O:
2.37%
H:
1.51%
C:
0.79%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-3.77%
|
O:
-0.65%
H:
1.63%
C:
1.48%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
-3.85%
|
O:
-0.88%
H:
1.46%
C:
1.13%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-0.15%
|
O:
1.67%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
8.85%
|
O:
-2.81%
H:
2.08%
C:
1.38%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
-3.5%
|
O:
-0.35%
H:
1.15%
C:
0.96%
lung
reach
cancer
cell
diagnostics
therapy
market
9.18% CAGR growth in Cancer Biologics Market by Product (Monoclonal antibodies, Cell and gene therapy, vaccines, and others), Route Of Administration, and Geography- Global forecast to 2028
Published:
2024-02-19
(Crawled : 16:00)
- prnewswire.com
BIIB
|
$193.18
-0.48%
-0.48%
1.4M
|
Health Technology
|
Email alert
Add to watchlist
VTRS
|
News
A
|
$11.36
0.98%
0.97%
4.7M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
Email alert
Add to watchlist
JAZZ
|
$109.685
0.79%
0.78%
380K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
Email alert
Add to watchlist
cancer
cell
global
growth
market
Breast Cancer Therapeutics Market 2023, USD 15.64 billion Growth is Expected between 2023 to 2028, Robust pipeline and new drug approvals to Boost Growth - Technavio
Published:
2024-01-30
(Crawled : 18:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
1.27%
|
O:
5.68%
H:
0.77%
C:
0.77%
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
6.9%
|
O:
3.41%
H:
0.0%
C:
-2.45%
VTRS
|
News
A
|
$11.36
0.98%
0.97%
4.7M
|
Health Technology
|
-3.81%
|
O:
-0.08%
H:
3.47%
C:
-0.25%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-8.25%
|
O:
-2.04%
H:
0.19%
C:
-1.97%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
5.5%
|
O:
4.04%
H:
1.57%
C:
-3.02%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
2.8%
|
O:
0.5%
H:
0.07%
C:
-0.81%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-6.39%
|
O:
1.75%
H:
0.0%
C:
0.0%
PBYI
|
$5.12
-0.97%
-0.98%
290K
|
Health Technology
|
7.66%
|
O:
-0.1%
H:
2.31%
C:
-1.26%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
5.43%
|
O:
0.82%
H:
0.12%
C:
-1.64%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
-13.06%
|
O:
0.44%
H:
0.2%
C:
-0.55%
drug
breast
expected
cancer
pipeline
therapeutics
growth
market
Cancer Immunotherapy Market to grow by USD 38.57 billion from 2022 to 2027, North America to account for 41% of market growth- Technavio
Published:
2024-01-04
(Crawled : 23:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
0.1%
|
O:
2.46%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-7.46%
|
O:
0.49%
H:
0.6%
C:
-0.83%
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
2.37%
|
O:
0.15%
H:
1.88%
C:
-1.17%
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
-8.57%
|
O:
-0.24%
H:
1.43%
C:
1.43%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-6.36%
|
O:
0.32%
H:
0.93%
C:
0.38%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
5.55%
|
O:
-0.36%
H:
0.98%
C:
0.72%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-7.74%
|
O:
-0.14%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
3.01%
|
O:
-0.68%
H:
0.87%
C:
0.1%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
-9.77%
|
O:
-0.32%
H:
0.44%
C:
0.26%
america
cancer
immunotherapy
market
Fallopian Tube Cancer Therapeutics Market size to grow by USD 832.01 million from 2023-2028| AbbVie Inc., Amgen Inc., Arrien Pharmaceuticals LLC and more among the key companies in the market - Technavio
Published:
2023-12-05
(Crawled : 23:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
10.33%
|
O:
1.64%
H:
0.0%
C:
-1.33%
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
11.57%
|
O:
1.51%
H:
0.13%
C:
-1.68%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
1.95%
|
O:
0.52%
H:
0.18%
C:
-0.43%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
13.52%
|
O:
-0.03%
H:
0.28%
C:
-0.41%
BAX
|
$41.02
1.54%
0.0%
2.6M
|
Health Technology
|
14.58%
|
O:
0.14%
H:
0.78%
C:
0.22%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
17.27%
|
O:
0.26%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
10.69%
|
O:
0.73%
H:
0.06%
C:
-1.38%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
0.99%
|
O:
0.2%
H:
0.2%
C:
-0.76%
GOOGL
|
News
S
|
$158.17
1.21%
1.19%
21M
|
Technology Services
|
21.73%
|
O:
1.97%
H:
0.0%
C:
0.0%
GOOG
|
News
4
|
$159.82
1.18%
1.17%
16M
|
Technology Services
|
21.65%
|
O:
1.97%
H:
0.0%
C:
0.0%
ADBE
A
|
$472.955
1.3%
1.28%
2.1M
|
Technology Services
|
-21.47%
|
O:
0.97%
H:
0.08%
C:
-2.03%
tube
companies
abbvie
cancer
pharmaceuticals
therapeutics
market
Changing the Trajectory of Breast Cancer in Europe: How Advanced Screening Can Make a Difference
Published:
2023-10-18
(Crawled : 23:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
8.56%
|
O:
0.0%
H:
0.0%
C:
-2.39%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
13.64%
|
O:
-1.24%
H:
0.06%
C:
-1.26%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-12.43%
|
O:
-2.42%
H:
0.0%
C:
0.0%
breast
cancer
Global Cancer Vaccine Industry Worth $13.4 Billion by 2030: Use of Nanosensors in Diagnosing Cancer Expected to Create Ample Opportunities for Key Players
Published:
2023-06-27
(Crawled : 10:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
7.57%
|
O:
-1.1%
H:
0.0%
C:
0.0%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
13.7%
|
O:
-0.91%
H:
0.56%
C:
-0.5%
MRNA
|
News
S
|
$107.87
3.26%
3.16%
2.4M
|
Health Technology
|
-10.4%
|
O:
0.03%
H:
0.37%
C:
0.18%
DVAX
|
$11.75
-0.76%
-0.77%
1.4M
|
Health Technology
|
-8.98%
|
O:
0.08%
H:
1.31%
C:
0.77%
vaccine
expected
cancer
global
Global Cancer Therapies Strategic Business Report 2023: Industry Focuses on New Approaches to Treat Cancer
Published:
2023-06-27
(Crawled : 01:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
7.57%
|
O:
-1.1%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.38
0.15%
0.9%
1.7M
|
Health Technology
|
-15.38%
|
O:
-0.95%
H:
0.19%
C:
-0.32%
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-28.65%
|
O:
0.19%
H:
0.11%
C:
-1.46%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-0.65%
|
O:
-0.01%
H:
0.16%
C:
-0.32%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-8.54%
|
O:
0.03%
H:
0.12%
C:
-0.24%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
13.7%
|
O:
-0.91%
H:
0.56%
C:
-0.5%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
63.23%
|
O:
2.15%
H:
1.18%
C:
0.43%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-24.39%
|
O:
-0.06%
H:
0.46%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
-1.23%
|
O:
-0.21%
H:
0.42%
C:
0.13%
report
business
cancer
treat
global
New Drugs in Fight Against Cancer Being Powered by Novel Mechanisms of Action
Published:
2023-06-08
(Crawled : 22:00)
- biospace.com/
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
20.02%
|
O:
0.41%
H:
0.68%
C:
0.64%
PGEN
|
$1.4
1.45%
1.43%
510K
|
Health Technology
|
6.06%
|
O:
0.0%
H:
0.76%
C:
-4.55%
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-30.82%
|
O:
0.63%
H:
1.87%
C:
-1.25%
ITOS
|
$11.0
1.95%
1.91%
300K
|
Health Technology
|
-29.23%
|
O:
-0.52%
H:
3.23%
C:
-2.2%
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
-11.9%
|
O:
-0.42%
H:
3.56%
C:
3.48%
cancer
Global Peptide Therapeutics Market Report 2023: Increasing Prevalence of Cancer and Metabolic Disorders Drives Growth
Published:
2023-06-08
(Crawled : 02:00)
- prnewswire.com
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
-4.49%
|
O:
0.07%
H:
0.0%
C:
-1.7%
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
17.13%
|
O:
1.32%
H:
0.0%
C:
-0.62%
TAK
|
News
|
$13.38
0.15%
0.9%
1.7M
|
Health Technology
|
-17.06%
|
O:
-0.62%
H:
0.88%
C:
0.81%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
0.37%
|
O:
1.26%
H:
1.08%
C:
0.91%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
20.02%
|
O:
0.41%
H:
0.68%
C:
0.64%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
69.36%
|
O:
-0.11%
H:
2.66%
C:
2.24%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-24.82%
|
O:
0.28%
H:
0.42%
C:
-0.05%
BNTX
|
News
|
$88.53
0.59%
0.59%
360K
|
Health Technology
|
-19.12%
|
O:
0.39%
H:
0.15%
C:
-0.79%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
-3.36%
|
O:
-0.23%
H:
1.83%
C:
1.52%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
23.63%
|
O:
0.0%
H:
0.28%
C:
-0.23%
metabolic
report
cancer
global
therapeutics
growth
market
Targeted Therapy Global Market Report 2023: Increasing Prevalence of Cancer Drives Growth
Published:
2023-05-15
(Crawled : 17:00)
- prnewswire.com
GNMSF
|
News
|
$289.67
3.83%
5.3K
|
Health Technology
|
-30.92%
|
O:
0.24%
H:
0.66%
C:
0.66%
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
10.61%
|
O:
-1.1%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.38
0.15%
0.9%
1.7M
|
Health Technology
|
-18.53%
|
O:
0.61%
H:
0.3%
C:
0.24%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-4.15%
|
O:
0.2%
H:
0.13%
C:
-0.22%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
12.89%
|
O:
0.27%
H:
0.6%
C:
0.41%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-13.0%
|
O:
0.38%
H:
0.0%
C:
0.0%
GMAB
|
News
|
$28.54
-1.48%
-1.51%
560K
|
Health Technology
|
-31.49%
|
O:
0.38%
H:
0.91%
C:
0.69%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
17.42%
|
O:
0.14%
H:
0.28%
C:
0.11%
report
cancer
global
therapy
growth
market
Breast Cancer Screening Global Market Report 2023: Sector to Reach $2.12 Billion by 2028 at a 5.2% CAGR
Published:
2023-05-05
(Crawled : 22:00)
- prnewswire.com
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
Email alert
Add to watchlist
report
breast
reach
cancer
global
market
Zentalis to present positive clinical data in ovarian cancer combining azenosertib and chemotherapy, including at the 2023 ASCO Annual Meeting
Published:
2023-04-26
(Crawled : 15:00)
- biospace.com/
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
2.68%
|
O:
-4.57%
H:
0.22%
C:
-1.98%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
11.73%
|
O:
-0.03%
H:
0.3%
C:
-2.63%
ZNTL
|
$12.58
-3.23%
-3.34%
380K
|
Health Technology
|
-42.31%
|
O:
-0.23%
H:
0.18%
C:
-1.43%
asco
positive
cancer
meeting
Zentalis to present positive clinical data in ovarian cancer combining azenosertib and chemotherapy, including clinical support for Cyclin E1 expression as predictive marker for clinical benefit from azenosertib at the 2023 ASCO Annual Meeting
Published:
2023-04-26
(Crawled : 14:20)
- globenewswire.com
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
2.68%
|
O:
-4.57%
H:
0.22%
C:
-1.98%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
11.73%
|
O:
-0.03%
H:
0.3%
C:
-2.63%
ZNTL
|
$12.58
-3.23%
-3.34%
380K
|
Health Technology
|
-42.31%
|
O:
-0.23%
H:
0.18%
C:
-1.43%
asco
positive
cancer
meeting
Global Gastric Cancer Drugs Market Report 2023: Increasing Number of Obesity Cases and the Smoking Population Drives Growth
Published:
2023-04-20
(Crawled : 15:20)
- prnewswire.com
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
5.62%
|
O:
-0.08%
H:
0.0%
C:
-0.68%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
11.67%
|
O:
-0.24%
H:
0.0%
C:
-1.03%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
99.49%
|
O:
0.25%
H:
1.26%
C:
0.92%
DHR
|
$253.11
7.21%
0.0%
6.8M
|
Health Technology
|
-0.65%
|
O:
-3.83%
H:
1.9%
C:
1.36%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-15.45%
|
O:
-0.03%
H:
0.0%
C:
0.0%
obesity
report
cancer
global
growth
market
Breast cancer therapeutics market size grow by USD 13.85 billion between 2021 to 2026; AbbVie Inc. and Amgen Inc., among others, emerge as key vendors - Technavio
Published:
2023-04-13
(Crawled : 09:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
5.34%
|
O:
0.54%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-16.78%
|
O:
-1.1%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
-4.72%
|
O:
0.0%
H:
1.63%
C:
1.63%
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
19.63%
|
O:
1.25%
H:
0.51%
C:
0.51%
VTRS
|
News
A
|
$11.36
0.98%
0.97%
4.7M
|
Health Technology
|
15.68%
|
O:
0.31%
H:
1.42%
C:
0.71%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
2.48%
|
O:
1.3%
H:
0.56%
C:
0.51%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
9.36%
|
O:
0.85%
H:
0.76%
C:
0.76%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
4.42%
|
O:
-0.84%
H:
1.16%
C:
1.05%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-15.84%
|
O:
0.29%
H:
0.0%
C:
0.0%
PBYI
|
$5.12
-0.97%
-0.98%
290K
|
Health Technology
|
76.29%
|
O:
-0.34%
H:
10.17%
C:
6.9%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
-3.95%
|
O:
0.39%
H:
1.05%
C:
0.97%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
9.64%
|
O:
-0.36%
H:
1.33%
C:
1.14%
abbvie
breast
cancer
therapeutics
market
Non-melanoma Skin Cancer Market size to grow at a CAGR of 5.76% from 2021 to 2026, Driven by the NMSC coverage and support - Technavio
Published:
2023-04-12
(Crawled : 23:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
5.34%
|
O:
0.54%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
19.63%
|
O:
1.25%
H:
0.51%
C:
0.51%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
2.48%
|
O:
1.3%
H:
0.56%
C:
0.51%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
9.36%
|
O:
0.85%
H:
0.76%
C:
0.76%
BHC
|
$8.53
0.95%
0.0%
4M
|
Health Technology
|
15.58%
|
O:
1.49%
H:
3.07%
C:
0.67%
ICAD
|
$1.58
3.95%
3.8%
100K
|
Technology Services
|
5.41%
|
O:
1.35%
H:
0.0%
C:
-1.33%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
9.64%
|
O:
-0.36%
H:
1.33%
C:
1.14%
cancer
skin
market
Phase III RUBY clinical trial demonstrates potential of Jemperli (dostarlimab-gxly) plus chemotherapy to redefine the treatment of primary advanced or recurrent endometrial cancer versus chemotherapy alone
Published:
2023-03-27
(Crawled : 23:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
14.87%
|
O:
3.17%
H:
0.0%
C:
0.0%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
17.69%
|
O:
0.26%
H:
0.17%
C:
-0.09%
ANAB
|
$19.21
-2.29%
-2.34%
390K
|
Health Technology
|
-12.42%
|
O:
0.23%
H:
0.36%
C:
-1.59%
cancer
treatment
trial
plus
potential
Non-hodgkin lymphoma therapeutics market size to increase by USD 5,427.51 million between 2022 and 2027; Growing awareness about cancer as a key trend - Technavio
Published:
2023-03-24
(Crawled : 19:00)
- prnewswire.com
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
Email alert
Add to watchlist
BIIB
|
$193.18
-0.48%
-0.48%
1.4M
|
Health Technology
|
Email alert
Add to watchlist
BAX
|
$41.02
1.54%
0.0%
2.6M
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
Email alert
Add to watchlist
SGEN
|
$228.74
0.1%
20M
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
Email alert
Add to watchlist
cancer
growing
therapeutics
market
Skin Cancer Drugs Global Market Research Report 2023 with Focus on vismodegib (Erivedge) and sonidegib (Odomzo) - Forecasts to 2027 and 2032
Published:
2023-03-01
(Crawled : 02:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
11.98%
|
O:
-2.15%
H:
1.67%
C:
-0.03%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-1.15%
|
O:
-1.29%
H:
0.0%
C:
-0.13%
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
37.72%
|
O:
-1.3%
H:
0.0%
C:
0.0%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
17.52%
|
O:
0.18%
H:
0.26%
C:
-0.53%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
20.34%
|
O:
-0.15%
H:
0.38%
C:
0.12%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-0.51%
|
O:
-0.11%
H:
0.0%
C:
0.0%
ICAD
|
$1.58
3.95%
3.8%
100K
|
Technology Services
|
-41.13%
|
O:
1.13%
H:
7.84%
C:
5.97%
research
global
report
skin
cancer
market
← Previous
1
2
3
Next →
Gainers vs Losers
78%
22%
Top 10 Gainers
MTTR
|
News
4
|
$4.6
164.37%
62.17%
28M
|
AGBA
|
$2.94
135.2%
57.48%
66M
|
Finance
EDBL
|
News
|
$6.46
71.81%
41.8%
2M
|
MTC
|
$2.25
44.23%
30.67%
6M
|
Technology Services
OPRT
|
News
|
$3.175
41.11%
29.13%
12M
|
Finance
SHIM
|
$3.05
35.56%
26.23%
1.1M
|
HKIT
|
$1.345
31.86%
24.16%
390K
|
Technology Services
ABVC
|
$1.36
30.77%
23.53%
7.4M
|
Wholesale Trade
OST
|
$0.512
28.0%
21.88%
290K
|
POET
|
$1.59
27.2%
21.38%
4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.